80 related articles for article (PubMed ID: 8386309)
21. 12-hydroperoxyeicosatetraenoic acid inhibits main platelet functions by activation of soluble guanylate cyclase.
Brüne B; Ullrich V
Mol Pharmacol; 1991 May; 39(5):671-8. PubMed ID: 1674588
[TBL] [Abstract][Full Text] [Related]
22. Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris.
Chirkov YY; Chirkova LP; Horowitz JD
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):520-5. PubMed ID: 8897457
[TBL] [Abstract][Full Text] [Related]
23. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
24. Formation of extracellular cGMP in blood mononuclear and platelet cell preparations.
Williams WR; Kagamimori S; Davies BH; Watanabe M
J Clin Lab Immunol; 1986 Jun; 20(2):89-92. PubMed ID: 3016277
[TBL] [Abstract][Full Text] [Related]
25. Platelet activation by diacylglycerol or ionomycin is inhibited by nitroprusside.
Doni MG; Deana R; Padoin E; Ruzzene M; Alexandre A
Biochim Biophys Acta; 1991 Sep; 1094(3):323-9. PubMed ID: 1655043
[TBL] [Abstract][Full Text] [Related]
26. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR
J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of platelet adhesion to collagen by cGMP-elevating agents.
Wu CC; Ko FN; Teng CM
Biochem Biophys Res Commun; 1997 Feb; 231(2):412-6. PubMed ID: 9070290
[TBL] [Abstract][Full Text] [Related]
28. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of antiplatelet and antithrombotic activity of midazolam in in vitro and in vivo studies.
Hsiao G; Shen MY; Chou DS; Chang Y; Lee LW; Lin CH; Sheu JR
Eur J Pharmacol; 2004 Mar; 487(1-3):159-66. PubMed ID: 15033388
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of alcohol on cyclic GMP accumulation in human platelets.
Dong QS; Wroblewska B; Myers AK
Thromb Res; 1995 Oct; 80(2):143-51. PubMed ID: 8588191
[TBL] [Abstract][Full Text] [Related]
31. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles.
Ding KH; Abdel-Latif AA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2629-38. PubMed ID: 9375582
[TBL] [Abstract][Full Text] [Related]
32. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
Chen R; Liang N
Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
[TBL] [Abstract][Full Text] [Related]
33. Nitroprusside differentially inhibits ADP-stimulated calcium influx and mobilization in human platelets.
Morgan RO; Newby AC
Biochem J; 1989 Mar; 258(2):447-54. PubMed ID: 2539806
[TBL] [Abstract][Full Text] [Related]
34. Elevation of cAMP, but not cGMP, inhibits thrombin-stimulated tyrosine phosphorylation in human platelets.
Pumiglia KM; Huang CK; Feinstein MB
Biochem Biophys Res Commun; 1990 Sep; 171(2):738-45. PubMed ID: 1698364
[TBL] [Abstract][Full Text] [Related]
35. Cyclic GMP and nitroprusside inhibit the activation of human platelets by fluoroaluminate.
Deana R; Ruzzene M; Doni MG; Zoccarato F; Alexandre A
Biochim Biophys Acta; 1989 Nov; 1014(2):203-6. PubMed ID: 2573392
[TBL] [Abstract][Full Text] [Related]
36. Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase C.
MacIntyre DE; Bushfield M; Shaw AM
FEBS Lett; 1985 Sep; 188(2):383-8. PubMed ID: 2993027
[TBL] [Abstract][Full Text] [Related]
37. Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation.
Schinner E; Salb K; Schlossmann J
Platelets; 2011; 22(3):217-27. PubMed ID: 21244222
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets.
Nakashima S; Tohmatsu T; Hattori H; Okano Y; Nozawa Y
Biochem Biophys Res Commun; 1986 Mar; 135(3):1099-104. PubMed ID: 3008741
[TBL] [Abstract][Full Text] [Related]
39. [New approaches to the study of the mechanism of action of nitrates].
Mukharliamov NM; Negresku EV; Sazonova LN; Men'shikov MIu; Baldenkov GN
Ter Arkh; 1988; 60(8):21-7. PubMed ID: 2852408
[TBL] [Abstract][Full Text] [Related]
40. Platelet release reaction and intracellular cGMP.
Weiss A; Baenziger NL; Atkinson JP
Blood; 1978 Sep; 52(3):524-31. PubMed ID: 209839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
